Collectively, this work provides preclinical support for a multi-pronged strategy in which CAF normalization via disruption of the CXCL12–CXCR4 pathway enhances immune infiltration while constraining tumor growth and metastasis [144]. This evidence concerns the gene CXCR4 and neoplasm.